1. Home
  2. DSWL vs IMMP Comparison

DSWL vs IMMP Comparison

Compare DSWL & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Deswell Industries Inc.

DSWL

Deswell Industries Inc.

HOLD

Current Price

$3.46

Market Cap

58.9M

Sector

Industrials

ML Signal

HOLD

Logo Immutep Limited

IMMP

Immutep Limited

HOLD

Current Price

$0.44

Market Cap

61.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSWL
IMMP
Founded
1987
1987
Country
Macau
Australia
Employees
N/A
N/A
Industry
Plastic Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.9M
61.4M
IPO Year
2000
2012

Fundamental Metrics

Financial Performance
Metric
DSWL
IMMP
Price
$3.46
$0.44
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$5.50
AVG Volume (30 Days)
19.7K
417.3K
Earning Date
06-17-2026
05-12-2026
Dividend Yield
5.90%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$445.09
Revenue Next Year
N/A
N/A
P/E Ratio
$4.59
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.67
$0.29
52 Week High
$4.48
$3.53

Technical Indicators

Market Signals
Indicator
DSWL
IMMP
Relative Strength Index (RSI) 46.27 58.23
Support Level $3.19 $0.42
Resistance Level $3.53 $0.56
Average True Range (ATR) 0.16 0.03
MACD -0.01 0.01
Stochastic Oscillator 26.67 99.37

Price Performance

Historical Comparison
DSWL
IMMP

About DSWL Deswell Industries Inc.

Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.

About IMMP Immutep Limited

Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-004, TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.

Share on Social Networks: